castrate resistant prostate adenocarcinoma
Showing 1 - 25 of >10,000
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
-
Detroit, Michigan
- +1 more
Aug 30, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Metastatic Castration-resistant Prostate Cancer, Adenocarcinoma of the Prostate Trial in Pécs (Selegiline, Docetaxel)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Adenocarcinoma of the Prostate
-
Pécs, Baranya, HungaryUniversity of Pécs, Clinical Centre, Department of Oncotherapy
Oct 7, 2020
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity
Recruiting
- Prostate Cancer Metastatic
- +3 more
- High Intensity Interval Training
-
San Antonio, TexasUT Health San Antonio
Feb 17, 2022
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)
Recruiting
- Nasopharyngeal Carcinoma
- +8 more
-
Springdale, ArkansasHighlands Oncology
Nov 11, 2022
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- cabozantinib-s-malate
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 3, 2021
Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)
Not yet recruiting
- Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
- TmPSMA-02 CAR T Cells
- (no location specified)
Sep 13, 2023
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)
Suspended
- Castrate-Resistant Prostate Cancer
- LIGHT-PSMA-CART cells
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jan 25, 2023
Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)
Not yet recruiting
- Metastasis Castration Resistant Prostate Cancer(mCRPC)
- (no location specified)
Aug 14, 2023
Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco
Not yet recruiting
- Castrate Resistant Prostate Cancer
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 1, 2023
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- docetaxel
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 2, 2021
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- [177Lu]Lu-PSMA-617
- +3 more
- (no location specified)
Jan 23, 2023
Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)
Not yet recruiting
- Prostatic Neoplasms
- Castration-Resistant
- (no location specified)
Dec 1, 2022
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023
Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- Adenocarcinoma, Prostate
-
Birmingham, Alabama
- +4 more
Mar 29, 2021
Prostate Cancer Trial in Houston (Alpharadin)
Completed
- Prostate Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 16, 2022
Prostate Carcinoma Metastatic to the Bone, Stage IV Prostate Adenocarcinoma, Hormone-refractory Prostate Cancer Trial in United
Active, not recruiting
- Prostate Carcinoma Metastatic to the Bone
- +2 more
- Niraparib
- Radium Ra 223 Dichloride
-
Birmingham, Alabama
- +5 more
Feb 10, 2021
Castrate-Resistant Prostate Cancer Trial in Hangzhou (PD1-PSMA-CART cells)
Recruiting
- Castrate-Resistant Prostate Cancer
- PD1-PSMA-CART cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University
Feb 26, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in
Recruiting
- Castration Levels of Testosterone
- +4 more
- HER2Bi-Armed Activated T Cells
- +2 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Feb 26, 2021
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Prostate Cancer Trial in Philadelphia (CART-PSMA-TGFßRDN cells, Cyclophosphamide, Fludarabine)
Recruiting
- Prostate Cancer
- CART-PSMA-TGFβRDN cells
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 17, 2022
Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- mCRPC
- Sipuleucel-T
- Stereotactic Ablative Body Radiation
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 11, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Apalutamide
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 20, 2023